Every stakeholder with an interest in equitable access to medicines should be alarmed and consider acting in response to the process that led to the reimbursement of two oral COVID-19 antiviral treatments. …
This is just the latest example of selective decision-making
July 19, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Medical research powering Australia’s health and economic future
March 31, 2026 - - Latest News -
A silent crisis in plain sight as arthritis burden grows while research funding falls behind
March 31, 2026 - - Latest News -
A new opportunity for biosimilars as sector leaders gather in Canberra
March 31, 2026 - - Latest News -
Those who recognise and respond to the reality will be better positioned to shape reforms
March 31, 2026 - - Latest News -
Alterity Therapeutics updates investors on key meeting with US regulator
March 30, 2026 - - Australian Biotech -
Aroa Biosurgery reports promising trial milestone for advanced wound treatment
March 30, 2026 - - Australian Biotech -
Genetic Signatures reshapes its business to cut costs and drive growth
March 30, 2026 -